New approaches to understanding p53 gene tumor mutation spectra
- 29 December 1999
- journal article
- review article
- Published by Elsevier in Mutation Research
- Vol. 431 (2), 199-209
- https://doi.org/10.1016/s0027-5107(99)00162-1
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Clonal analysis of urothelial carcinomas in C3H/HeNBALB/c chimeric mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamineCarcinogenesis: Integrative Cancer Research, 1998
- Lack of p53 and ras mutations in Helicobacter hepaticus-induced liver tumors in A/JCr miceCarcinogenesis: Integrative Cancer Research, 1997
- Conditional gene targeting.Journal of Clinical Investigation, 1996
- Lack of p53 point mutations in chemically induced mouse hepatoblastomas: an end-stage, highly malignant hepatocellular tumorCancer Letters, 1995
- Rare occurrence of p53 and ras gene mutations in preneoplastic and neoplastic mouse endometrial lesions induced by N-methyl-N-nitrosourea and 17β-estradiolCancer Letters, 1995
- Frequent p53 alterations but low incidence of ras mutations in UV-B-induced skin tumors of hairless miceCarcinogenesis: Integrative Cancer Research, 1995
- Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic MutationsScience, 1994
- Infrequent p53 mutations in 7,12‐dimethylbenz[a]anthracene–induced mammary tumors in BALB/c and p53 hemizygous miceMolecular Carcinogenesis, 1994
- Screening forp53 mutations in c3h/he mouse liver tumors derived spontaneously or induced with diethylnitrosamine or phenobarbitoneMolecular Carcinogenesis, 1994
- Absence of MDM‐2 gene amplification in experimentally induced tumors regardless of p53 statusMolecular Carcinogenesis, 1994